| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405082A2 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 04/07/2004 | EP1405079A2 Modulation of the interaction between evh1 domains |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404870A2 Function and application of tob gene in central nervous system of mammal |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404834A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/07/2004 | EP1404833A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404828A1 A crystallised catalytic domain of matrix metalloproteinase 9 (mmp9) and the use of its three dimensional structure to design mmp9 modulators |
| 04/07/2004 | EP1404820A2 50365, a hexokinase family member and uses therefor |
| 04/07/2004 | EP1404807A2 20 human secreted proteins |
| 04/07/2004 | EP1404806A1 Male contraceptives |
| 04/07/2004 | EP1404718A2 Inhibitors of memapsin 2 and use thereof |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404713A1 Novel keratinocyte growth factor-2 analogue in hair follicle |
| 04/07/2004 | EP1404710A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 04/07/2004 | EP1404709A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/07/2004 | EP1404706A2 Mycobacterial antigens expressed during latency |
| 04/07/2004 | EP1404705A1 Compositions and methods of using hiv vpr |
| 04/07/2004 | EP1404704A1 Bridged bicyclic serine protease inhibitors |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404702A2 Human secreted proteins |
| 04/07/2004 | EP1404699A2 Antisense modulation of src-c expression |
| 04/07/2004 | EP1404698A2 Antisense modulation of superoxide dismutase 1, soluble expression |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404654A2 Calcilytic compounds |
| 04/07/2004 | EP1404516A2 Microencapsulation of drugs by solvent exchange |
| 04/07/2004 | EP1404412A1 Treatment and composition for wound healing |
| 04/07/2004 | EP1404378A1 Methods and apparatus relating to treatment systems using light for the treatment of fluid products |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404366A2 Combination therapy of gamma-interferon and b cell specific antibodies |
| 04/07/2004 | EP1404365A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 04/07/2004 | EP1404364A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity |
| 04/07/2004 | EP1404362A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 04/07/2004 | EP1404361A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404358A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2004 | EP1404357A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 04/07/2004 | EP1404355A1 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404354A2 Chemically-modified progenipoietin conjugates |
| 04/07/2004 | EP1404353A2 Methods of using a hyaluronan receptor |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404346A2 Calcium phosphate delivery vehicles for osteoinductive proteins |
| 04/07/2004 | EP1404334A1 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 04/07/2004 | EP1404333A1 Oxymorphone controlled release formulations |
| 04/07/2004 | EP1404307A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 04/07/2004 | EP1404305A1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 04/07/2004 | EP1404300A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 04/07/2004 | EP1404299A2 Particles for inhalation having rapid release properties |
| 04/07/2004 | EP1404298A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 04/07/2004 | EP1404268A1 Treating epidermlyosis bullosa with thymosin beta 4 |
| 04/07/2004 | EP1404264A2 Insert for the treatment of dry eye |
| 04/07/2004 | EP1404180A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 04/07/2004 | EP1404178A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1399180A4 Sulfated ccr5 peptides for hiv-1 infection |
| 04/07/2004 | EP1294412A4 Method of using lectins for contraception and prophylaxis agains t diseases transmittable by sexual contact and condom containing lectins |
| 04/07/2004 | EP1234031A4 B7-h1, a novel immunoregulatory molecule |
| 04/07/2004 | EP1218404A4 A binding motif of a receptor |
| 04/07/2004 | EP1183043B1 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors |
| 04/07/2004 | EP1151004B1 Method for producing il-1ra, a therapeutically active protein from body fluids |
| 04/07/2004 | EP1124843B1 Low allergenic protein variants |
| 04/07/2004 | EP1087783B1 Use of gastrin fragments or synthetic analogs of gastrin for the manufacture of a medicament for the treatment of helicobacter pylori-associated disorders |
| 04/07/2004 | EP1037648B1 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 04/07/2004 | EP0889905B1 Cytokine antagonists and agonists |
| 04/07/2004 | EP0888543A4 Azatide peptidomimetics |
| 04/07/2004 | EP0789561B1 Oral cyclosporin formulations |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0720483B1 Use of growth hormone in the manufacture of a medicament for the treatment of ischaemic brain damage and dementia |
| 04/07/2004 | EP0712312B1 Suppression of inhibitors |
| 04/07/2004 | EP0683791B1 Aqueous protein composition, glycoprotein contained therein, prepration method therefor and uses thereof |
| 04/07/2004 | EP0679098B1 Osseointegration promoting implant composition, implant assembly and use |
| 04/07/2004 | EP0549742B1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |
| 04/07/2004 | CN1487967A A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487952A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 04/07/2004 | CN1487951A Peptides having affinity for the GP 120 viral protein and use thereof |
| 04/07/2004 | CN1487843A A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1487837A Novel mixtures of microbial enzymes |
| 04/07/2004 | CN1487836A Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 04/07/2004 | CN1487833A Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/07/2004 | CN1487825A Process for preparing particles |
| 04/07/2004 | CN1487085A Conotoxin MVÔàí A and Trx fusion protein and its expression and application |
| 04/07/2004 | CN1487081A Cloning and expression of Baimei pit viper Aidingbit CDNA for treating tumor |
| 04/07/2004 | CN1486744A Application of neutral proteinase in preparing medicine for anorectal diseases and the medicine |
| 04/07/2004 | CN1486692A Plant extractive for treating cancer |
| 04/07/2004 | CN1144817C Novel human 'beta' 2 integrin 'alpha' sub unit |
| 04/07/2004 | CN1144816C Novel antproliferative protein from bacillus thuringiensis var. Thuringiensis |
| 04/07/2004 | CN1144814C Compound poultry lymphatic factor and producing process thereof |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144597C Method for preparing genetic antibiotic peptide medicine for animals from transgenic antibiotic peptide muscidian vermicule and its application |
| 04/07/2004 | CN1144584C Sustained-release compositions and method for preparing the same |
| 04/06/2004 | US6717030 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 04/06/2004 | US6716975 Antisense modulation of EDG1 expression |
| 04/06/2004 | US6716974 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 04/06/2004 | US6716968 Apoptosis-related antigenic compounds of specified amino acid sequence; inhibition of cell apoptosis; antibodies for stimulation of cell apoptosis; immunoassay to determine rate of apoptosis in tissues |